Is Compass Pathways a Good Stock to Buy Now?
Shares of Compass Pathways (NASDAQ: CMPS) have soared since the company's recent stock market debut as support grows for the use of popular recreational drugs to combat depression.
Can the highly refined version of magic mushrooms that Compass Pathways is developing for depression give your portfolio a lift too? Let's weigh some reasons investors are excited about this alternative biotech stock against some of the challenges that lie ahead.
Image source: Getty Images.
Source Fool.com
